The whole "COVID will be great for 4DX" was a reasonable assumption but not "make or break" for the company. 4DX has been around for several years and has always stated that the market in the US for lung diagnostics is massive - in the billions of dollars - without COVID.
In my view COVID has become an obstacle for 4DX in that it has been difficult to get an audience with hospitals in the US. Having said that, we seem to tracking ahead of schedule so I reckon the vaccine and reduced infections in the US will be great for 4DX!
The whole "COVID will be great for 4DX" was a reasonable...
-
- There are more pages in this discussion • 2,699 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.5¢ |
Change
0.005(0.94%) |
Mkt cap ! $219.6M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 53.5¢ | 51.5¢ | $87.23K | 165.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1972 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.5¢ | 18244 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |